J Korean Med Sci.  2007 Dec;22(6):1082-1084. 10.3346/jkms.2007.22.6.1082.

Morganella Morganii Sepsis with Massive Hemolysis

Affiliations
  • 1Department of Internal Medicine, Inje University Ilsan Paik Hospital, Goyang, Korea. leehr@ilsanpaik.ac.kr
  • 2Department of Laboratory Medicine, Inje University Ilsan Paik Hospital, Goyang, Korea.
  • 3Department of Thoracic Surgery, Inje University Ilsan Paik Hospital, Goyang, Korea.

Abstract

Morganella morganii is a facultative gram-negative and anaerobic rod. It may be a cause of devastating infections in neonates and immunocompromised hosts. Some bacterial infections such as Clostridium and Vibrio are associated with hemolysis. However, massive hemolysis caused by M. morganii sepsis has not yet been reported. We observed a 59-yr-old man who had chemotherapy-induced neutropenia and was found to have massive hemolysis and metabolic acidosis due to sepsis. He died 6 hr after admission in spite of aggressive treatment. Two sets of blood cultures revealed the growth of M. morganii. We report here that M. morganii sepsis can cause fatal massive hemolysis leading to death.

Keyword

Morganella Morganii; Sepsis; Hemolysis

MeSH Terms

Antineoplastic Agents/adverse effects
Bacteremia/*complications
Enterobacteriaceae Infections/*complications
*Hemolysis
Humans
Male
Middle Aged
*Morganella morganii
Neutropenia/complications

Reference

1. Kilcoyne M, Shashkov AS, Senchencova SA, Knirel YA, Vinogradov EV, Radziejewska-Lebrecht J, Galimska-Stypa R, Savage AV. Structural investigation of the O-specific polysaccharides of Morganella morganii consisting of two higher sugars. Carbohydr Res. 2002. 337:1697–1702.
Article
2. Crawford J, Dale DC, Lyman GH. Chemotherapy-induced neutropenia: risks, consequences and new directions for its management. Cancer. 2004. 100:228–237.
3. Becker RC, Giuliani M, Savage RA, Weick JK. Massive hemolysis in Clostridium perfringens infections. J Surg Oncol. 1987. 35:13–18.
4. Yamanaka H, Satoh T, Katsu T, Shinoda S. Mechanism of haemolysis by Vibrio vulnificus haemolysin. J Gen Microbiol. 1987. 133:2859–2864.
Article
5. Vento S, Cainelli F. Infection in patients with cancer undergoing chemotherapy: aetiology, prevention, and treatment. Lancet Oncol. 2003. 4:595–604.
6. McDermott C, Mylotte JM. Morganella morganii: epidemiology of bacteremic disease. Infect Control. 1984. 5:131–137.
Article
7. Salen PN, Eppes S. Morganella morganii: a newly reported, rare cause of neonatal sepsis. Acad Emerg Med. 1997. 4:711–714.
Article
8. Lee IK, Liu JW. Clinical characteristics and risk factors for mortality in Morganella morganii bacteremia. J Microbiol Immunol Infect. 2006. 39:328–334.
9. Gutierrez A, Florencio R, Ezpeleta C, Cisterna R, Martinez M. Fatal intravascular hemolysis in a patient with Clostridium perfringens septicemia. Clin Infect Dis. 1995. 20:1064–1065.
Article
10. Arnaout MK, Tamburro RF, Bodner SM, Sandlund JT, Rivera GK, Pui CH, Ribeiro RC. Bacillus cereus causing fulminant sepsis and hemolysis in two patients with acute leukemia. J Ped Hematol Oncol. 1999. 21:431–435.
Article
11. Eberspacher B, Hugo F, Pohl M, Bhakdi S. Functional similarity between the haemolysins of Escherichia coli and Morganella morganii. Med Microbiol. 1990. 33:165–170.
Article
Full Text Links
  • JKMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr